Igene Biotechnology, Inc.
Symbole: IGNE
PNK
0.000001
USDPrix du marché aujourd'hui
-0.0109
Ratio P/E
-0.0001
Ratio PEG
0.11M
Cap MRK
- 0.00%
Rendement DIV
Igene Biotechnology, Inc. (IGNE) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1.3 | 1.5 | 1 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-receivables | 0 | 2.3 | 1 | 2.7 | |||||||||
balance-sheet.row.inventory | 0 | 0 | 2.4 | 8.1 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 3.7 | 5 | 11.8 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0.9 | 0.8 | 0.7 | |||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 0.1 | 0.1 | 0.1 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0.1 | 0.1 | 0.1 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | 0.1 | 0.4 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 1.1 | 1.1 | 1.3 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 4.8 | 6.1 | 13.1 | |||||||||
balance-sheet.row.account-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.short-term-debt | 0 | 1.1 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.7 | 5.4 | 19.3 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5.9 | 5.9 | 19.6 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 7.5 | 8.7 | 27.5 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 15.6 | 15.2 | 1.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -52.9 | -52.7 | -48.7 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0.1 | 0 | 0 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 34.5 | 34.9 | 33.3 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | -2.7 | -2.7 | -14.4 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4.8 | 6.1 | 13.1 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | - | - | - | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-debt | 0 | 6.8 | 5.4 | 19.3 | |||||||||
balance-sheet.row.net-debt | 0 | 5.5 | 3.9 | 18.3 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -0.1 | -4 | -1.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.2 | 0.1 | 0 | |||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 2.1 | 7.3 | 1.7 | |||||||||
cash-flows.row.account-receivables | 0 | 1 | 1.7 | -3.7 | |||||||||
cash-flows.row.inventory | 0 | 2.4 | 5.7 | 1.8 | |||||||||
cash-flows.row.account-payables | 0 | 0 | -4.3 | 0 | |||||||||
cash-flows.row.other-working-capital | 0 | -1.3 | 0 | 3.5 | |||||||||
cash-flows.row.other-non-cash-items | 0 | -2.2 | -2.8 | 1.5 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.2 | -0.2 | -0.3 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -0.1 | |||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.2 | -0.2 | -0.4 | |||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | -0.7 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0 | 0.8 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 0 | 0.1 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -0.2 | 0.5 | 1 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1.3 | 1.5 | 1 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1.5 | 1 | 0 | |||||||||
cash-flows.row.operating-cash-flow | 0 | -0.1 | 0.7 | 1.3 | |||||||||
cash-flows.row.capital-expenditure | 0 | -0.2 | -0.2 | -0.3 | |||||||||
cash-flows.row.free-cash-flow | 0 | -0.3 | 0.5 | 1 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 4 | 7.6 | 2.3 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 2.9 | 6.4 | 1.7 | |||||||||
income-statement-row.row.gross-profit | 0 | 1 | 1.2 | 0.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.operating-expenses | 0 | 1 | 3.4 | 0.5 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 3.9 | 9.8 | 2.2 | |||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 2 | 2.2 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 1 | 0.2 | 0 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | 1 | 0.2 | 0 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 2 | 2.2 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.2 | 0.1 | 0 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -1.1 | -2.2 | 0.2 | |||||||||
income-statement-row.row.income-before-tax | 0 | 0 | -2 | 0.3 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 0.2 | 1.8 | 2 | |||||||||
income-statement-row.row.net-income | 0 | -0.1 | -4 | -1.9 |
Questions fréquemment posées
Quel est le total de Igene Biotechnology, Inc. (IGNE) de l'actif total?
Igene Biotechnology, Inc. (IGNE) Le total des actifs est 4759763.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.257.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.000.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.036.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.270.
Qu'est-ce que Igene Biotechnology, Inc. (IGNE) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -140747.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 6796435.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 990930.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.